pI: 6.2799 |
Length (AA): 459 |
MW (Da): 52813 |
Paralog Number:
6
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_126822)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G20470 | AGC (cAMP-dependent, cGMP-dependent and protein kinase C) kinase family protein |
Arabidopsis thaliana | AT2G19400 | AGC kinase family protein |
Arabidopsis thaliana | AT3G23310 | AGC (cAMP-dependent, cGMP-dependent and protein kinase C) kinase family protein |
Arabidopsis thaliana | AT4G33080 | AGC (cAMP-dependent, cGMP-dependent and protein kinase C) kinase family protein |
Arabidopsis thaliana | AT1G30640 | protein kinase family protein |
Arabidopsis thaliana | AT5G09890 | Protein kinase family protein |
Arabidopsis thaliana | AT1G03920 | putative serine/threonine protein kinase |
Arabidopsis thaliana | AT4G14350 | AGC (cAMP-dependent, cGMP-dependent and protein kinase C) kinase family protein |
Brugia malayi | Bm1_29575 | Protein kinase domain containing protein |
Candida albicans | CaO19.4909 | similar to S. cerevisiae cell wall biosynthesis kinase, nuclear protein kinase involved in morphogenesis during mating |
Candida albicans | CaO19.12375 | similar to S. cerevisiae cell wall biosynthesis kinase, nuclear protein kinase involved in morphogenesis during mating |
Caenorhabditis elegans | CELE_T20F10.1 | Protein WTS-1 |
Caenorhabditis elegans | CELE_R11G1.4 | Protein SAX-1, isoform B |
Cryptosporidium hominis | Chro.10143 | CBK1 |
Cryptosporidium hominis | Chro.20198 | hypothetical protein |
Cryptosporidium parvum | cgd2_1830 | hypothetical protein |
Dictyostelium discoideum | DDB_G0288753 | NDR family protein kinase |
Dictyostelium discoideum | DDB_G0278457 | NDR family protein kinase |
Drosophila melanogaster | Dmel_CG8637 | tricornered |
Drosophila melanogaster | Dmel_CG12072 | warts |
Echinococcus granulosus | EgrG_000896700 | NDR protein kinase |
Echinococcus granulosus | EgrG_000700100 | NDR protein kinase |
Entamoeba histolytica | EHI_002790 | protein kinase, putative |
Entamoeba histolytica | EHI_068600 | protein kinase, putative |
Entamoeba histolytica | EHI_110490 | protein kinase, putative |
Echinococcus multilocularis | EmuJ_000700100 | serine:threonine protein kinase LATS2 |
Echinococcus multilocularis | EmuJ_000896700 | serine:threonine protein kinase 38 |
Giardia lamblia | GL50803_8587 | Kinase, AGC NDR |
Homo sapiens | ENSG00000150457 | large tumor suppressor kinase 2 |
Homo sapiens | ENSG00000112079 | serine/threonine kinase 38 |
Homo sapiens | ENSG00000211455 | serine/threonine kinase 38 like |
Homo sapiens | ENSG00000131023 | large tumor suppressor kinase 1 |
Leishmania braziliensis | LbrM.06.1160 | protein kinase, putative |
Leishmania donovani | LdBPK_061220.1 | protein kinase, putative |
Leishmania infantum | LinJ.06.1220 | protein kinase, putative |
Leishmania major | LmjF.06.1180 | protein kinase, putative |
Leishmania mexicana | LmxM.06.1180 | protein kinase, putative |
Loa Loa (eye worm) | LOAG_00928 | AGC/NDR protein kinase |
Loa Loa (eye worm) | LOAG_07025 | AGC/NDR protein kinase |
Mus musculus | ENSMUSG00000024006 | serine/threonine kinase 38 |
Mus musculus | ENSMUSG00000040021 | large tumor suppressor |
Mus musculus | ensembl-mmu:ENSMUSG00000001630 | serine/threonine kinase 38 like |
Mus musculus | ENSMUSG00000021959 | large tumor suppressor 2 |
Oryza sativa | 9271850 | Os12g0290100 |
Oryza sativa | 4339288 | Os05g0511400 |
Oryza sativa | 4348888 | Os10g0476100 |
Oryza sativa | 4325661 | Os01g0186700 |
Saccharomyces cerevisiae | YNL161W | Cbk1p |
Schistosoma japonicum | Sjp_0203020 | Serine/threonine-protein kinase 38-like, putative |
Schistosoma japonicum | Sjp_0203030 | Serine/threonine-protein kinase 38-like, putative |
Schistosoma mansoni | Smp_103570 | serine/threonine protein kinase |
Schistosoma mansoni | Smp_171920 | serine/threonine protein kinase |
Schmidtea mediterranea | mk4.000628.06 | |
Schmidtea mediterranea | mk4.002603.02 | |
Schmidtea mediterranea | mk4.001772.03 | |
Schmidtea mediterranea | mk4.003800.01 | Serine/threonine-protein kinase tricorner |
Schmidtea mediterranea | mk4.003789.01 | Serine/threonine-protein kinase tricorner |
Trypanosoma brucei gambiense | Tbg972.7.6700 | protein kinase, putative |
Trypanosoma brucei | Tb927.7.5770 | Nuclear Dbf2-related kinase |
Trypanosoma congolense | TcIL3000_7_4740 | protein kinase, putative |
Trypanosoma cruzi | TcCLB.508173.170 | Nuclear Dbf2-related kinase |
Trichomonas vaginalis | TVAG_009500 | AGC family protein kinase |
Trichomonas vaginalis | TVAG_378200 | AGC family protein kinase |
Trichomonas vaginalis | TVAG_508070 | AGC family protein kinase |
Trichomonas vaginalis | TVAG_400740 | AGC family protein kinase |
Trichomonas vaginalis | TVAG_036320 | AGC family protein kinase |
Trichomonas vaginalis | TVAG_118330 | AGC family protein kinase |
Trichomonas vaginalis | TVAG_310280 | AGC family protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.5770 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.5770 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.5770 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.7.5770 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T20F10.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_T20F10.1 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_T20F10.1 | Caenorhabditis elegans | slow growth | wormbase |
YNL161W | Saccharomyces cerevisiae | inviable | yeastgenome |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | serine/threonine kinase 38 | Compounds | References |
Homo sapiens | serine/threonine kinase 38 like | Compounds | References |
Homo sapiens | large tumor suppressor kinase 1 | Compounds | References |
Homo sapiens | large tumor suppressor kinase 2 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Patiria pectinifera | Cdc2 | 300 aa | 30.6% | 245 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 24.0% | 321 aa | Compounds | References |
Bos taurus | cAMP-dependent protein kinase alpha-catalytic subunit | 351 aa | 33.5% | 331 aa | Compounds | References |
Rattus norvegicus | Jak1 protein | 210 aa | 25.2% | 202 aa | Compounds | References |
Rattus norvegicus | cAMP-dependent protein kinase alpha-catalytic subunit | 351 aa | 33.0% | 336 aa | Compounds | References |
Oryctolagus cuniculus | cAMP-dependent protein kinase alpha-catalytic subunit | 351 aa | 32.3% | 331 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 25.9% | 317 aa | Compounds | References |
Rattus norvegicus | Serine/threonine-protein kinase pim-3 | 326 aa | 24.5% | 274 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 28.7% | 321 aa | Compounds | References |